AEPCX
Price
$60.66
Change
+$0.41 (+0.68%)
Updated
Nov 21 closing price
Net Assets
130.21B
AWPCX
Price
$21.26
Change
+$0.27 (+1.29%)
Updated
Nov 21 closing price
Net Assets
852.97M
Interact to see
Advertisement

AEPCX vs AWPCX

Header iconAEPCX vs AWPCX Comparison
Open Charts AEPCX vs AWPCXBanner chart's image
American Funds EUPAC C
Price$60.66
Change+$0.41 (+0.68%)
VolumeN/A
Net Assets130.21B
AB Sustainable Intl Thematic C
Price$21.26
Change+$0.27 (+1.29%)
VolumeN/A
Net Assets852.97M
AEPCX vs AWPCX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. AWPCX commentary
Nov 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and AWPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 130B vs. AWPCX (853M). AEPCX pays higher dividends than AWPCX: AEPCX (0.15) vs AWPCX (0.00). AEPCX was incepted earlier than AWPCX: AEPCX (25 years) vs AWPCX (31 years). AWPCX (1.81) is less costly to investors than AEPCX (1.57). AWPCX is a more actively managed with annual turnover of: 48.00 vs. AEPCX (35.00). AEPCX has a lower initial minimum investment than AWPCX: AEPCX (250) vs AWPCX (2500). AEPCX annual gain was more profitable for investors over the last year : 11.41 vs. AWPCX (3.18). AEPCX return over 5 years is better than : -0.26 vs. AWPCX (-12.15).
AEPCXAWPCXAEPCX / AWPCX
Total Expense Ratio1.571.8087%
Annual Report Gross Expense Ratio1.571.8187%
Fund Existence25 years31 years-
Gain YTD17.3996.213280%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets130B853M15,240%
Annual Yield % from dividends0.150.00-
Returns for 1 year11.413.18359%
Returns for 3 years28.1214.76191%
Returns for 5 years-0.26-12.152%
Returns for 10 years33.4113.08255%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LDWY3.600.18
+5.26%
Lendway
MNRO18.400.79
+4.49%
Monro
ATOS0.780.03
+3.76%
Atossa Therapeutics
LQDA29.110.55
+1.93%
Liquidia Corp
RPRX38.930.54
+1.41%
Royalty Pharma plc